Decided

No. 08-1509

Classen Immunotherapies, Inc. v. Biogen IDEC, et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

JUDGMENT ISSUED.

Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of Bilski v. Kappos, 561 U. S. ___ (2010). (orders list)

DISTRIBUTED for Conference of June 28, 2010.

Supplemental brief of respondent Merck & Co., Inc. filed. (Distributed)

DISTRIBUTED for Conference of November 24, 2009.

Supplemental brief of petitioner Classen Immunotherapies, Inc. filed.

Brief of respondent Biogen IDEC in opposition filed.

Response Requested . (Due October 22, 2009)

DISTRIBUTED for Conference of September 29, 2009.

Waiver of right of respondent Biogen IDEC to respond filed.

Brief of respondent Merck & Co., Inc. in opposition filed.

Brief of respondent GlaxoSmithKline in opposition filed.

Order extending time to file response to petition to and including August 7, 2009, for all respondents.

Petition for a writ of certiorari filed. (Response due July 8, 2009)

Parties

Classen Immunotherapies, Inc., Petitioner, represented by Roger Browdy

Classen Immunotherapies, Inc., Petitioner, represented by Joseph J. Zito

Biogen IDEC, Respondent, represented by Noah A. Levine

Biogen IDEC, Respondent, represented by Donald R. Ware

GlaxoSmithKline, Respondent, represented by George F. Pappas

Merck & Co., Inc., Respondent, represented by Mary B. Graham

 
Last updated: November 7, 2011